Trials / Unknown
UnknownNCT04162535
Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery
Contributions to the Elucidation of the Mechanisms and Effects by Which Certain Perianesthetic Interventions Modify Long-term Evolution of Patients With Digestive Cancers Subjected to Surgery
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Digestive cancers (liver, colonic, pancreatic) have a high incidence and high mortality, their population prevalence is also increasing. Given that the anesthesia techniques and the agents used act directly and indirectly on the immune system during the perioperative period, influencing both the treatment and the prognosis of patients with colorectal cancer who undergo elective interventions, a series of perianesthetic interventions have been proposed in order to reduce morbidity-mortality perioperative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine 1% Injectable Solution | Lidocaine 1% Injectable Solution Intervention Protocol for the TIVA and Lidocaine Arm * Induction: 1.5 mg / kg i.v. bolus before induction (at the vein catch). * Maintaining anesthesia: continuous infusion with Lidocaine 2 mg / kg / h, up to a maximum of 200 mg / h during maintenance (after IOT until waking) * Infusion with 1% Lidocaine will be reduced to 1.0- 1.5 mg / kg / hour, max 100 mg / hour, for the first 48 hours postop |
| BIOLOGICAL | Blood extraction | The patients will donate after consent 10 ml of blood prior and after surgery for further study |
| DRUG | Sevoflurane | Patients will receive a general volatile anesthesia with Sevoflurane as anesthetic agent |
| DRUG | Propofol | Patients will receive a general anesthesia with Propofol as anesthetic agent |
Timeline
- Start date
- 2018-11-26
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2019-11-14
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04162535. Inclusion in this directory is not an endorsement.